Logo image of MCFT

MASTERCRAFT BOAT HOLDINGS IN (MCFT) Stock Fundamental Analysis

NASDAQ:MCFT - Nasdaq - US57637H1032 - Common Stock - Currency: USD

20.18  +0.89 (+4.61%)

After market: 20.18 0 (0%)

Fundamental Rating

4

MCFT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 31 industry peers in the Leisure Products industry. MCFT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MCFT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MCFT had positive earnings in the past year.
In the past year MCFT had a positive cash flow from operations.
MCFT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years MCFT had a positive operating cash flow.
MCFT Yearly Net Income VS EBIT VS OCF VS FCFMCFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a Return On Assets value of -2.55%, MCFT perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
MCFT's Return On Equity of -3.67% is fine compared to the rest of the industry. MCFT outperforms 61.29% of its industry peers.
MCFT has a Return On Invested Capital of 1.55%. This is comparable to the rest of the industry: MCFT outperforms 58.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MCFT is significantly above the industry average of 7.11%.
The 3 year average ROIC (30.44%) for MCFT is well above the current ROIC(1.55%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.55%
ROE -3.67%
ROIC 1.55%
ROA(3y)13.84%
ROA(5y)10.06%
ROE(3y)26.89%
ROE(5y)16.74%
ROIC(3y)30.44%
ROIC(5y)27.79%
MCFT Yearly ROA, ROE, ROICMCFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

In the last couple of years the Profit Margin of MCFT has declined.
The Operating Margin of MCFT (1.35%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MCFT has declined.
MCFT has a worse Gross Margin (17.16%) than 77.42% of its industry peers.
In the last couple of years the Gross Margin of MCFT has declined.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 17.16%
OM growth 3Y-32.32%
OM growth 5Y-17.63%
PM growth 3Y-43.91%
PM growth 5Y-14.25%
GM growth 3Y-11.99%
GM growth 5Y-5.47%
MCFT Yearly Profit, Operating, Gross MarginsMCFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

7

2. Health

2.1 Basic Checks

MCFT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MCFT has been reduced compared to 1 year ago.
Compared to 5 years ago, MCFT has less shares outstanding
Compared to 1 year ago, MCFT has a worse debt to assets ratio.
MCFT Yearly Shares OutstandingMCFT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MCFT Yearly Total Debt VS Total AssetsMCFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MCFT has an Altman-Z score of 4.42. This indicates that MCFT is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.42, MCFT is doing good in the industry, outperforming 77.42% of the companies in the same industry.
MCFT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACC0.17
WACC8.96%
MCFT Yearly LT Debt VS Equity VS FCFMCFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

MCFT has a Current Ratio of 1.81. This is a normal value and indicates that MCFT is financially healthy and should not expect problems in meeting its short term obligations.
MCFT's Current ratio of 1.81 is in line compared to the rest of the industry. MCFT outperforms 41.94% of its industry peers.
A Quick Ratio of 1.23 indicates that MCFT should not have too much problems paying its short term obligations.
The Quick ratio of MCFT (1.23) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.23
MCFT Yearly Current Assets VS Current LiabilitesMCFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

3. Growth

3.1 Past

MCFT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.40%.
The earnings per share for MCFT have been decreasing by -16.07% on average. This is quite bad
MCFT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.66%.
The Revenue has been decreasing by -4.70% on average over the past years.
EPS 1Y (TTM)-81.4%
EPS 3Y-29.37%
EPS 5Y-16.07%
EPS Q2Q%-18.92%
Revenue 1Y (TTM)-41.66%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.7%
Sales Q2Q%-20.63%

3.2 Future

MCFT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.37% yearly.
MCFT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.52% yearly.
EPS Next Y-38.68%
EPS Next 2Y1.64%
EPS Next 3Y7.37%
EPS Next 5YN/A
Revenue Next Year-24.15%
Revenue Next 2Y-5.74%
Revenue Next 3Y-2.52%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCFT Yearly Revenue VS EstimatesMCFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
MCFT Yearly EPS VS EstimatesMCFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 42.04, which means the current valuation is very expensive for MCFT.
MCFT's Price/Earnings ratio is a bit cheaper when compared to the industry. MCFT is cheaper than 61.29% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.41, MCFT is valued quite expensively.
The Price/Forward Earnings ratio is 16.70, which indicates a correct valuation of MCFT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MCFT indicates a somewhat cheap valuation: MCFT is cheaper than 67.74% of the companies listed in the same industry.
MCFT is valuated cheaply when we compare the Price/Forward Earnings ratio to 33.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 42.04
Fwd PE 16.7
MCFT Price Earnings VS Forward Price EarningsMCFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MCFT.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.93
MCFT Per share dataMCFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.64%
EPS Next 3Y7.37%

0

5. Dividend

5.1 Amount

No dividends for MCFT!.
Industry RankSector Rank
Dividend Yield N/A

MASTERCRAFT BOAT HOLDINGS IN

NASDAQ:MCFT (8/12/2025, 4:07:10 PM)

After market: 20.18 0 (0%)

20.18

+0.89 (+4.61%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-28 2025-08-28/bmo
Inst Owners94.83%
Inst Owner Change-0.12%
Ins Owners1.9%
Ins Owner Change3.39%
Market Cap335.19M
Analysts74.55
Price Target19.13 (-5.2%)
Short Float %7.26%
Short Ratio11.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3020.15%
Min EPS beat(2)69.69%
Max EPS beat(2)5970.61%
EPS beat(4)4
Avg EPS beat(4)1608.56%
Min EPS beat(4)69.69%
Max EPS beat(4)5970.61%
EPS beat(8)8
Avg EPS beat(8)823.77%
EPS beat(12)12
Avg EPS beat(12)554.97%
EPS beat(16)16
Avg EPS beat(16)419.55%
Revenue beat(2)1
Avg Revenue beat(2)0.82%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)2.7%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)4.73%
Revenue beat(8)7
Avg Revenue beat(8)2.49%
Revenue beat(12)10
Avg Revenue beat(12)2.19%
Revenue beat(16)10
Avg Revenue beat(16)-1.38%
PT rev (1m)1.9%
PT rev (3m)-2.34%
EPS NQ rev (1m)1.11%
EPS NQ rev (3m)-47.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.21%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)-16.05%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-3.77%
Valuation
Industry RankSector Rank
PE 42.04
Fwd PE 16.7
P/S 1.23
P/FCF N/A
P/OCF 62.93
P/B 1.84
P/tB 2.76
EV/EBITDA 15.93
EPS(TTM)0.48
EY2.38%
EPS(NY)1.21
Fwd EY5.99%
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.32
OCFY1.59%
SpS16.37
BVpS10.96
TBVpS7.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.55%
ROE -3.67%
ROCE 1.9%
ROIC 1.55%
ROICexc 2.36%
ROICexgc 4.53%
OM 1.35%
PM (TTM) N/A
GM 17.16%
FCFM N/A
ROA(3y)13.84%
ROA(5y)10.06%
ROE(3y)26.89%
ROE(5y)16.74%
ROIC(3y)30.44%
ROIC(5y)27.79%
ROICexc(3y)35.88%
ROICexc(5y)32.97%
ROICexgc(3y)55.34%
ROICexgc(5y)62.02%
ROCE(3y)37.33%
ROCE(5y)34.08%
ROICexcg growth 3Y-41.98%
ROICexcg growth 5Y-41.71%
ROICexc growth 3Y-36.32%
ROICexc growth 5Y-19.49%
OM growth 3Y-32.32%
OM growth 5Y-17.63%
PM growth 3Y-43.91%
PM growth 5Y-14.25%
GM growth 3Y-11.99%
GM growth 5Y-5.47%
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 104.72%
Cap/Sales 3.81%
Interest Coverage 2.43
Cash Conversion 39.29%
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.23
Altman-Z 4.42
F-Score4
WACC8.96%
ROIC/WACC0.17
Cap/Depr(3y)182.78%
Cap/Depr(5y)184.82%
Cap/Sales(3y)3.83%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.4%
EPS 3Y-29.37%
EPS 5Y-16.07%
EPS Q2Q%-18.92%
EPS Next Y-38.68%
EPS Next 2Y1.64%
EPS Next 3Y7.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.66%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.7%
Sales Q2Q%-20.63%
Revenue Next Year-24.15%
Revenue Next 2Y-5.74%
Revenue Next 3Y-2.52%
Revenue Next 5YN/A
EBIT growth 1Y-92.66%
EBIT growth 3Y-37.52%
EBIT growth 5Y-21.5%
EBIT Next Year41.33%
EBIT Next 3Y39.34%
EBIT Next 5YN/A
FCF growth 1Y-104.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-96.28%
OCF growth 3Y-43.28%
OCF growth 5Y-25.89%